• Title/Summary/Keyword: Oral midazolam

검색결과 77건 처리시간 0.026초

Midazolam 투여시 선행성 건망증 발현에 관한 연구 (ANTEROGRADE AMNESIC EFFECT OF MIDAZOLAM)

  • 이정하;김미라;이난영;이상호
    • 대한소아치과학회지
    • /
    • 제31권3호
    • /
    • pp.412-420
    • /
    • 2004
  • 최근 의식하 진정요법에 많이 이용되고 있는 Midazolam의 임상적 효과로는 항불안, 진정, 수면, 항경련, 근이완, 기억상실 등이 있는데, 이중 기억상실효과는 주로 선행성 건망증(anterograde amnesia)으로 약물투여 후 약물의 작용이 지속되는 동안에 경험한 일들을 기억하지 못하는 현상이다. 이는 시술 중환자의 협조를 얻을 수 있으면서도 시술 후 환자는 시술중의 불편한 과정을 기억하지 못하는 효과를 얻을 수 있다는 임상적 장점이 있다. 본 연구는 Midazolam 투여 시 선행성 건망증의 발현 양상을 평가할 목적으로 약물에 대한 기왕력이 없으며 미국 마취학회 전신상태 평가기준에 따라 1등급으로 판정된 조선대학교 치과대학에 재학중인 학생 15명을 대상으로 위약, 경구용 Midazolam투여 주사용 Midazolam의 비강내 투여 후 Snograss와 Vanderwart에 의해 표준화된 260개 그림 시리즈를 이용하여 선행성 건망증의 발현정도를 평가한 결과 다음과 같은 결론을 얻었다. 1. Midazolam의 경구투여와 비강내 투여 시 선행성 건망증의 정도가 위약에 비해 유의하게 높았다(P<0.01). 2. Midazolam의 비강내 투여시 선행성 건망증의 정도가 경구투여보다 높았으나 유의한 차이는 없었다(P>0.01). 3. Midazolam의 경구투여와 비강내 투여 모두 약물투여 15분 후부터 선행성 건망증을 보이기 시작하여 경구투여시는 45분, 비강내 투여시는 30분에 가장 높은 효과를 보였다. 4. 약물투여 30분이 지나면서 비강내 투여보다 경구투여에서 선행성 건망증의 정도와 진정정도가 더 높았으나 유의한 차이는 없었다(P>0.01). 본 결과로 미루어 보아Midazolam을 투여한 후 선행성 건망증은 경구투여와 비강내 투여 모두 약물투여 15분 후부터 나타났으며 30분전까지는 비강내 투여에서, 30분이 지나면 경구투여에서 더 높은 효과를 보이는 경향이 관찰된 바, 치과치료 시 Midazolam의 경구투여와 비강내 투여를 이용한 의식진정요법을 시행함에 있어 국소마취 등의 고통스러운 과정은 최소 약물투여 15분 후 시행하는 것이 향후 치과진료에 대한 환자의 긍정적 자세를 유도하는데 도움이 되리라 사료된다.

  • PDF

Midazolam을 이용한 정주진정요법 (INTRAVENOUS SEDATION WITH MIDAZOLAM)

  • 이준석;김종수;김승오
    • 대한장애인치과학회지
    • /
    • 제2권2호
    • /
    • pp.142-146
    • /
    • 2006
  • 환아의 연령, 과다체중, 환아의 약물 거부 등으로 인하여 chloral hydrate를 이용한 수면치료가 불가능한 경우, Midazolam을 이용한 정주진정요법이 전신마취를 대신하는 대안으로 사용될 수 있다. 본 환아의 경우, 0.3mg/kg의 midazolam을 근주하고, 70% 아산화질소 가스를 이용하여 초기 수면상태를 유도하고 정맥천자를 실시한 후, 0.2mg/kg midazolam을 정주하여 50분간 별다른 부작용 없이 성공적으로 치료할 수 있었다.

  • PDF

하악 제3대구치 발치 시 midazolam을 사용한 정맥진정법의 진정효과에 관한 임상적 연구 (The clinical study on the sedative effect and recovery in patients undergoing intravenous conscious sedation with midazolam for mandibular third molars extraction)

  • 곽주희;장진현;김진우;김명래;김선종
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제36권5호
    • /
    • pp.408-412
    • /
    • 2010
  • Introduction: This study examined the depth of sedation and the usefulness of the monitoring tool in determining the level of sedation in patients undergoing third molars extraction under conscious sedation with midazolam. Materials and Methods: Twenty two patients undergoing third molars extraction at the department of Oral and Maxillofacial surgery, Ewha Womans Mokdong Hospital from February 2010 to April 2010 were analyzed. All patients were classified as American Society of Anesthesiologist (ASA) class I and had no contraindications tosedation. The bispectral index was recorded continually during surgery using a bispectral monitor. The initial sedation was accomplished using a 3 mg bolus of midazolam followed by a 2 mg bolus of midazolam until the level of sedation, at which the patient’s eyes were closed or the subject was responsive only to loud or repeated calling of their name, was reached. All subjects were surveyed with a postoperative questionnaire to evaluate the level of sedation. Results: The bispectral index (BIS) decreased approximately 5 minutes after midazolam administration, but increased at the local anesthesia injection and odontomy procedure. The amnestic effect was shown effectively in the early stages of surgery. Conclusion: Conscious sedation with intravenous midazolam is effective in achieving the effect of anxiolysis, analgesia and amnesia. The BIS is an objective and useful means of assessing the depth of sedation.

치과치료를 위한 정주진정법에 사용되는 미다졸람에 대한 역설적 반응 -증례 보고 및 문헌고찰- (Paradoxical Reaction to Midazolam Used in Intravenous Sedation for Dental Treatment -Report of a Case and Review of the Literature-)

  • 전재윤;정세화;이병하;임재중;황경균;심광섭;박창주
    • 대한치과마취과학회지
    • /
    • 제9권2호
    • /
    • pp.104-107
    • /
    • 2009
  • Midazolam, one of the most common benzodiazepine derivatives, is widely used in intravenous sedation for dental treatment without severe complications. However, paradoxical reactions to midazolam, including patient's unanticipated restlessness, agitation, hostility, and rage, have been frequently reported since the introduction of benzodiazepine. During outpatient intravenous sedation using midazolam for dental treatment, we experienced a paradoxical reaction to midazolam in a 28-year-old female patient. With a thorough review of the literature, the management of this complication and its various etiologies were discussed.

  • PDF

Midazolam을 이용한 의식하진정법을 시행한 환자에서 나타난 선행성 및 후행성 기억상실 (Retro- and Ante-grade Amnesia after Conscious Sedation using Midazolam)

  • 김영욱;금윤선;모동엽;이장렬;김현철;이상철
    • 대한치과마취과학회지
    • /
    • 제11권2호
    • /
    • pp.153-158
    • /
    • 2011
  • Midazolam is known to produce sedation as well as amnesia. Many articles reported about anterograde amnesia, but it is rare that articles about retrograde amnesia. The 61-year-old female patient (64 kg, 154 cm, ASA physical status I) was administered 3.02 mg (0.047 mg/kg) of midazolam during 2 hours. The patient's Modified Observer's Assesment of Alertness/Sedation Scale was 4. The patient who had been consciously sedated with midazolam, exhibited profound amnesia, both anterograde and retrograde after implantation. The patient's memory restoration was begun after 6 hours.

Midazolam과 국소 마취제를 이용한 정맥 내 진정법 시 치과 환자에서 관찰되는 변화에 대한 연구 (PROSPECTIVE CLINICAL STUDY OF MIDAZOLAM SEDATION IN PATIENTS UNDERGOING DENTAL PRACTICE)

  • 김성곤
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제34권2호
    • /
    • pp.131-134
    • /
    • 2008
  • Purpose: The objective of this study was to evaluate the clinical parameters in terms of the midazolam sedation in patients undergoing dental practice. Patients and Methods: Total 28 patients were included in this study. They received the dental practice in the daycare center and sedation was done with midazolam. The recorded variables were blood pressure, pulse rate, $SpO_2$, and patient's response. The differences between observations were analyzed with paired samples t-test. Results: The blood pressure was significantly decreased after the administration of midazolam and the systolic pressure was significantly increased at the start of operation (P<0.05). The pulse rate was significantly increased after lidocaine injection (P<0.001). The amnesic effect was shown 21 cases out of 28 cases (75%). Conclusions: The effect of midazolam on pulse rate was not significant. However, midazolam could decrease the blood pressure significantly. Therefore, the sedation with midazolam could be successfully used in the dental practice, particularly for the patients having the hypertension.

소아 환자에서 미다졸람의 경구 투여와 근육 투여에 의한 진정 효과의 비교 연구 (THE COMPARATIVE STUDY ON THE SEDATIVE EFFECT OF ORAL MIDAZOLAM AND INTRAMUSCULAR MIDAZOLAM IN SEDATING YOUNG PEDIATRIC DENIAL PATIENTS)

  • 민유진;유승훈;김종수
    • 대한소아치과학회지
    • /
    • 제33권1호
    • /
    • pp.53-61
    • /
    • 2006
  • 미다졸람은 소아 환자의 진정시 흔히 사용되는 약물로서 안전성이 뛰어나고 사용이 편리하며 투여 방법이 다양하다. 여러 투여 방법 중, 주로 사용되는 근육내 투여 방법은 동통을 유발하기 때문에 어린이의 치과에 대한 공포를 가중시킬 수 있다. 따라서 근육내 투여의 이런 단점을 완화할 수 있도록 용량에 따른 미다졸람 경구 투여의 진정 효과를 근육내 투여시의 진정 효과와 비교 평가하고자 하였다. 총 12명의 환자를 실험대상으로 하였으며 이중 맹검법에 의해 두 번의 내원중 임의로 한 번은 Midazolam 0.75 mg/kg을 경구 투여하고, 한 번은 미다졸람 0.3mg/kg을 근육내 투여하여 치료하였으며, 치료과정 동안 환자의 생징후(말초 동맥혈 산소 포화도, 심박수)와 행동양상을 Ohio State University Behavior rating scale과 Automated Counting System을 사용하여 평가하였다. 생징후의 경우 양 군 모두 정상범위 내에서 안정된 양상을 보였으며, 임상적으로 바람직한 행동양상(Q:Quiet)의 비율이양 군에서 대부분 높게 나타났으며 양군간에 유의 한 차이를 보이지 않았다(p>0.05). 본 연구에서 미다졸람을 근육내 투여한 군과 경구 투여한 군 모두 진정 효과가 양호한 결과를 보였으며 양군간에 유의한 차이를 보이지 않았다(pgt;0.05).

  • PDF

정맥하 진정요법에서 Midazolam 단독 사용과 Midazolam, Fentanyl 또는 Propofol 병용 요법의 비교 (Comparison of the Use of Midazolam only with Midazolam Combined with Fentanyl or Propofol in IV sedation)

  • 이동현;김재원;이상준;김재현;장태화;안상헌;장헌수
    • 대한치과마취과학회지
    • /
    • 제8권2호
    • /
    • pp.113-117
    • /
    • 2008
  • Background: The purpose of this study was to compare the use of midazolam only with midazolam with fentanyl or propofol in IV sedation. Methods: 24 cases were divided to midazolam group (M group), midazolam + fentanyl group (MF group), midazolam + propofol group (MP group) and midazolam + fentanyl + propofol group (MFP group). In M group, 2 ml midazolam was injected at first, than at 2 minutes interval 1-2 ml injected continuously depending on the level of sedation. In MP, MFP groups, propofol was injected at the speed of 15-20 ml/hr by infusion pump. In this study, the sedation level was evaluated by using OAA/S scale. In each groups, the recovery time was measured until OAA/S scale score level was 5, and pre and postoperative blood pressure change was measured. Each group's data was statistically analyzed using one-way ANOVA. If significant statistical difference were observed, Dunnet test was performed, and control group was M group. Results: Pre and postoperative blood pressure change were not represent significant statistical difference in 4 groups (P value = 0.679 [systolic], P value = 0.206 [diastolic]). But recovery time were represent significant statistical difference (M group: 35.6, MF group: 32.5, MP group: 17.9, MFP group: 19.6 [P value = 0.002]). The result of Dunnet test on recovery time showed significant statistical difference on MF, MFP group when M group was control group. In MFP group, sedation was increased by using supplemental fentanyl, and postoperative pain control was dominant. Conclusion: To achieve the effect of anxiolysis, analgesia, amnesia effectively, and short recovery time, MFP group is mostly recommended.

  • PDF

임플란트 수술을 위한 미다졸람 정주와 아산화질소 흡입 병용 진정법의 효과와 안전성에 대한 전향적 무작위 대조군 연구 (A Prospective, Randomized and Controlled Study for the Efficacy and Safety of Sedation Technique for Implant Surgery by Combining Nitrous Oxide and Intravenous Midazolam)

  • 전승환;정신혜;김광수;전상호;황경균;박창주
    • 대한치과마취과학회지
    • /
    • 제12권2호
    • /
    • pp.69-74
    • /
    • 2012
  • Background: The purpose of this study is to investigate the efficacy and safety of the sedation technique for implant surgery by combining the use of inhalation of nitrous oxide/oxygen with intravenous midazolam. Methods: Patients requiring surgery for the placement of dental implants were randomly allocated to two groups receiving intravenous midazolam or a combined technique using nitrous oxide/oxide and intravenous midazolam. Safety parameters, cooperation scores, anxiety scales, total amount of midazolam administered and recovery time were recorded and compared. Results: There were a statistically significant reduction in the amount of midazolam required to achieve optimal sedation (P<0.01), an overall significant reduction in recovery time (P<0.01), a significant reduction in anxiety scales (P<0.05), and a significant improvement in cooperation (P<0.05) and peripheral oxygen saturation (P<0.05) when a combined technique of inhalational $N_2O/O_2$ and midazolam was used. Conclusions: For implant surgery, this combining sedation technique could be safe and reliable, demonstrating reduction of total dose of midazolam and level of patient's anxiety and improvement in patient's recovery and cooperation.

자폐증 환자의 행동조절을 위한 Midazolam Intranasal Spray 사용사례 (Use of Midazolam Intranasal Spray for Dental Treatment of Autism Patients)

  • 송영균;이숙영;김승오
    • 대한치과마취과학회지
    • /
    • 제12권4호
    • /
    • pp.223-227
    • /
    • 2012
  • Autism patients in general have bad oral hygiene. It is hard for autism patients to get dental treatment as poor communication. Therefore, they may have to be treated by deep sedation or general anesthesia in numerous cases. However, this process requires induction with mask, so it is not easy to do for disobliging autism patient. Midazolam is a water-soluble benzodiazepine, has been used in pediatric dentistry or dentistry for the handicapped because of rapid onset. Midazolam can be administered through oral, rectal, intramuscular,intravenous, and intranasal (IN) routes. IN route of midazolam may be considered as effective way to allay for uncooperative autism patients before general anesthesia. In this case report, two autism patients required dental treatment. Intranasal spray of midazolam before general anesthesia was safe and effective procedure of behavioral management.